Top Markets
#1 Official Trump Official Trump +36.17%
#2 Siacoin Siacoin +22.83%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +19.38%
#4 Melania Meme Melania Meme +19.00%
#5 Pump.fun Pump.fun +18.96%
#6 Unit Pump Unit Pump +18.96%
#7 EXOD EXOD +18.93%
#8 MowCat MowCat +18.45%
#9 Mubarak Mubarak +17.59%
#10 POL (ex-MATIC) POL (ex-MATIC) +16.45%
Coin of the day
Official Trump Official Trump
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Modern Chinese Medicine Group Co., Ltd. Modern Chinese Medicine Group Co., Ltd.

Modern Chinese Medicine Group Co., Ltd.

1643
Pozycja w akcjach #23125
As an investment holding company, Modern Chinese Medicine Group Co., Ltd.... As an investment holding company, Modern Chinese Medicine Group Co., Ltd. manufactures and distributes traditional Chinese pharmaceutical products, primarily targeting the middle-aged and elderly populations across the People's Republic of China. Its extensive product line provides treatments for a wide array of health issues, including qi deficiency, blood stasis, cardiovascular and cerebrovascular conditions, digestive and gastrointestinal ailments, gynecological problems, as well as disorders affecting the respiratory and nervous systems. Established in 1986, the enterprise maintains its principal offices in Chengde, China, and operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.
Cena akcji
$0.1087373
Ostatnia synchronizacja: 2026-08-21
Kapitalizacja rynkowa
$78.29M
Zmiana (1 dzień)
3.66%
Zmiana (1 rok)
18.02%
Kraj
CN
Handel Modern Chinese Medicine Group Co., Ltd. (1643)

Kategoria

Healthcare
Zyski dla Modern Chinese Medicine Group Co., Ltd. (1643)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Modern Chinese Medicine Group Co., Ltd., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Modern Chinese Medicine Group Co., Ltd. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT